Use left and right arrow keys to seek audio. AMD first teased 3D V-Cache in 2021 on a 12-core Ryzen 9 5900X prototype, yet the only Zen 3 X3D chips it went on to sell topped out at eight cores. Now a ...

For more than a century, pharmaceutical companies have relied on flat structures called aromatic rings, which can help drugs bind to target sites in the body. They include benzene rings and other flat ...

本内容遵循CC 4.0 BY-SA版权协议 Adobe Substance 3D Sampler 2021是微软最新推出的一款3D图像制作软件，这款软件可以帮助用户将现实中真实事务图片转化为逼真的3D素材，而且素材无限贴近原始的真实 ...

The Gnomon Workshop has released Design Mechs in VR Using Substance 3D Modeler, a free guide to VR sculpting workflow, recorded by WB Games concept artist Andre-Lang Huynh. The workshop provides 30 ...

The HP Z Captis 3D scanner for converting complex physical material properties into digital assets, has been given further capabilities in a new update integrating it with Adobe Substance 3D Sampler.

Adobe's Substance 3D Painter 12.1 adds OpenPBR support, Auto Rebake, and Skew Map Painting, part of a wider OpenPBR rollout across Substance 3D tools and assets. Adobe has rolled out a set of ...

Adobe has released Substance 3D Sampler 6.0, the latest version of its material authoring and 3D capture software. The update adds support for the OpenPBR material standard, introduces new templates ...

Appropriately for a story about family dynasties, A Woman of Substance comes to BritBox with a substantial legacy to live up to. Originally a 1979 novel by Barbara Taylor Bradford, it was first ...

EXCLUSIVE: Channel 4 has given a second season order to A Woman of Substance, its most-streamed drama since It’s a Sin. The renewal comes more than 40 years after the iconic original, an adaptation of ...

While none of the flaws have been exploited in the wild, many of them could lead to arbitrary code execution. Adobe on Tuesday announced the release of patches for 52 vulnerabilities across 10 ...

今回のアップデートでは、業界の新たな標準となるOpenPBRへの対応をはじめ、高度なマテリアルを素早く作成できるプリセット機能、柔軟なオーサリングを可能にするプロパティパネルの再 ...

Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart. Rodent models are limited by ...